Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
about
Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progressionMolecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.Update on meningiomas.DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours.Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningiomaBrain tumours: classification and genesDNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays.Meningioma pathology, genetics, and biology.Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?Genetic/molecular alterations of meningiomas and the signaling pathways targeted.Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell cloneProposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype.Gone FISHing: clinical lessons learned in brain tumor molecular diagnostics over the last decade.MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas.Genetic landscape of meningioma.Functional significance of S6K overexpression in meningioma progression.Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.Loss of heterozygosity studies in extracranial metastatic meningiomas.New approaches for the treatment of refractory meningiomas.Clinicopathological and molecular characteristics of pediatric meningiomas.Genetic alterations associated with progression and recurrence in meningiomas.Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.Early malignant transformation of a petroclival meningothelial meningioma.Molecular and genetic profiles of radiographically defined de novo meningiomas.Expression of p40 (∆Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role.Radiation effects on human leptomeningeal cell response to cerebrospinal fluid and PDGF-BB.[Meningiomas: multiparametric approach for risk stratification and grading].Emerging Medical Treatments for Meningioma in the Molecular Era
P2860
Q26741529-AE9DDC46-1DC5-4D6A-857E-EBCFD37917A9Q28115872-89A10EE3-6A66-46F3-8BE0-2DF2272E31EFQ30440977-2C2CC820-8DEC-401D-B3D2-2BAE858FD21CQ30447293-2FD1454D-31C7-4851-9C88-9110EE3F4B56Q30461960-D4147556-19B7-4CA2-9C3A-3240F045DC60Q30542025-4598F2E8-2FDF-4FD4-B656-986A8EA364BBQ33269178-BA4DD59A-5D58-4D40-9F76-6F7B820F919CQ35072568-074D97D4-67FB-43AC-940B-1D769364EF98Q35576526-47957505-8702-4C4E-89CB-37DF288AFB52Q35584376-936F149C-2637-4DF5-A773-1F3AA5A46F5EQ35747646-F89C1AAC-FE81-4D3C-B92B-8AFC2A2BD3F1Q35751662-9BE1F255-28CF-49E9-8A48-AC7F6613686DQ35789787-BFF720F5-D2A1-4D8D-9268-45D2123DEA67Q35793582-D15F7D3E-E8C9-4869-B0BA-8F96E0D78E9BQ35800821-3621F55D-7E4A-46CD-9D90-03B9F14B5B8FQ36013346-7D009D32-000A-4544-A2D4-99F71CEF1960Q37699436-7E44E34E-0547-4913-932B-94DD4D40F12BQ37815544-B1F0EB28-12ED-4879-AA97-5898A57FF6A0Q38073178-93C9E858-8006-4F67-B3C4-7201C9CB4F1DQ38953562-B338CB68-A720-44D1-A820-42080E8ED7C3Q40491430-ABCD1F4D-15A5-4DC9-A6F6-7A5FED6CC844Q40494023-E3B88C0F-AE6C-43D9-83D4-D0814A591855Q48191734-57771768-D17E-48FF-9E7E-4E0B7ABEDA5BQ48326740-B8A3C152-4D05-44B7-945B-7F1FCE19A710Q48355463-65655A43-0C61-4673-ADAF-036DC723A043Q48382150-9B005EA5-FC3C-4EC9-B7CE-A897E0601D59Q48447232-CAC40481-038D-444B-BB75-4DF44ADA73BBQ48762572-CBF67B8B-ADCC-405F-A825-81DDDDA4E34BQ50444489-9ED6BCC4-8A82-4C20-A2D8-7BF47F2141C9Q51365595-08E6ABCC-467F-49FC-8F04-E0AD80527226Q51653192-9AE08518-F6E2-49BC-8CA6-33933876A44AQ53170708-BEC588B1-1343-4DEE-BA17-7B3D42BFDA38Q53452099-C3236484-5DF3-41DC-BCBB-5C3570AF9CEBQ58798211-A9D3014F-C3B2-4FB5-9FF3-D4D5D27B956A
P2860
Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Chromosome 1p and 14q FISH ana ...... c and prognostic implications.
@en
Chromosome 1p and 14q FISH ana ...... c and prognostic implications.
@nl
type
label
Chromosome 1p and 14q FISH ana ...... c and prognostic implications.
@en
Chromosome 1p and 14q FISH ana ...... c and prognostic implications.
@nl
prefLabel
Chromosome 1p and 14q FISH ana ...... c and prognostic implications.
@en
Chromosome 1p and 14q FISH ana ...... c and prognostic implications.
@nl
P2093
P2860
P356
P1476
Chromosome 1p and 14q FISH ana ...... c and prognostic implications.
@en
P2093
Banerjee R
Kleinschmidt-Demasters BK
Scheithauer BW
P2860
P304
P356
10.1093/JNEN/60.6.628
P577
2001-06-01T00:00:00Z